163 related articles for article (PubMed ID: 18662409)
21. Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations.
Hansen TV; Jønson L; Steffensen AY; Andersen MK; Kjaergaard S; Gerdes AM; Ejlertsen B; Nielsen FC
Fam Cancer; 2011 Jun; 10(2):207-12. PubMed ID: 21318380
[TBL] [Abstract][Full Text] [Related]
22. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.
Malone KE; Daling JR; Thompson JD; O'Brien CA; Francisco LV; Ostrander EA
JAMA; 1998 Mar; 279(12):922-9. PubMed ID: 9544766
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
Belogianni I; Apessos A; Mihalatos M; Razi E; Labropoulos S; Petounis A; Gaki V; Keramopoulos A; Pandis N; Kyriacou K; Hadjisavvas A; Kosmidis P; Yannoukakos D; Nasioulas G
BMC Cancer; 2004 Sep; 4():61. PubMed ID: 15353005
[TBL] [Abstract][Full Text] [Related]
24. BRCA1 germline mutations in Cypriot breast cancer patients from 26 families with family history.
Hadjisavvas A; Neuhausen SL; Hoffman MD; Adamou A; Newbold RF; Kyriacou KC; Christodoulou CG
Anticancer Res; 2001; 21(5):3307-11. PubMed ID: 11848488
[TBL] [Abstract][Full Text] [Related]
25. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
26. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families.
Tesoriero AA; Wong EM; Jenkins MA; Hopper JL; Brown MA; Chenevix-Trench G; Spurdle AB; Southey MC;
Hum Mutat; 2005 Nov; 26(5):495. PubMed ID: 16211554
[TBL] [Abstract][Full Text] [Related]
28. Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history.
Dufloth RM; Carvalho S; Heinrich JK; Shinzato JY; dos Santos CC; Zeferino LC; Schmitt F
Sao Paulo Med J; 2005 Jul; 123(4):192-7. PubMed ID: 16389418
[TBL] [Abstract][Full Text] [Related]
29. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
[TBL] [Abstract][Full Text] [Related]
30. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
[TBL] [Abstract][Full Text] [Related]
31. Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Cypriot family.
Hadjisavvas A; Adamou A; O'Dowd Phanis C; Todd CM; Kitsios P; Kyriacou K; Christodoulou CG
Oncol Rep; 2002; 9(2):383-6. PubMed ID: 11836613
[TBL] [Abstract][Full Text] [Related]
32. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
33. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.
Katagiri T; Kasumi F; Yoshimoto M; Nomizu T; Asaishi K; Abe R; Tsuchiya A; Sugano M; Takai S; Yoneda M; Fukutomi T; Nanba K; Makita M; Okazaki H; Hirata K; Okazaki M; Furutsuma Y; Morishita Y; Iino Y; Karino T; Ayabe H; Hara S; Kajiwara T; Houga S; Miki Y
J Hum Genet; 1998; 43(1):42-8. PubMed ID: 9609997
[TBL] [Abstract][Full Text] [Related]
34. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
[TBL] [Abstract][Full Text] [Related]
35. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
[TBL] [Abstract][Full Text] [Related]
36. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
Newman B; Mu H; Butler LM; Millikan RC; Moorman PG; King MC
JAMA; 1998 Mar; 279(12):915-21. PubMed ID: 9544765
[TBL] [Abstract][Full Text] [Related]
37. Detection of BRCA1 and BRCA2 gene mutation in Egyptian females with breast cancer and their relatives by PCR-SSCP method.
Fattouh M; Ahmed H; Hafez Eel-S
Egypt J Immunol; 2011; 18(1):9-16. PubMed ID: 23082475
[TBL] [Abstract][Full Text] [Related]
38. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
39. BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.
Vaidyanathan K; Lakhotia S; Ravishankar HM; Tabassum U; Mukherjee G; Somasundaram K
J Biosci; 2009 Sep; 34(3):415-22. PubMed ID: 19805903
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.
Miramar MD; Calvo MT; Rodriguez A; Antón A; Lorente F; Barrio E; Herrero A; Burriel J; García de Jalón A
Breast Cancer Res Treat; 2008 Nov; 112(2):353-8. PubMed ID: 18176857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]